![Martin Olin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Olin
Président chez
CESSATECH A/S
Profil
Martin Olin is currently Chief Executive Officer at Swarm Oncology Ltd. since 2024.
Mr. Olin is Chairman at Cessatech A since 2022, Chairman at RSP Systems A, Chairman at Dan Group Alarm AS, and Director at AirHelp Ltd. Formerly, Mr. Olin was Chief Executive Officer at Oncoinvent ASA from 2021 to 2024 and Chief Executive Officer at Servier Symphogen.
A from 2016 to 2020.
Mr. Olin was Managing Partner at Fiftyfive Capital A from 2020 to 2021 and Finance Director at Novo Nordisk A from 1996 to 2000.
Other former roles include Chairman at PreciSense A, Independent Chairman at AcouSort AB, Independent Director at Ascendis Pharma A from 2014 to 2018, Investment Director at SLS Invest ApS in 2012, Managing Director at Nordic Eye Management ApS, Senior Partner at Scandinavian Life Science Ventures AB, Senior Investment Manager at Scandinavian Life Science Invest ApS, Principal at PricewaterhouseCoopers (Denmark), and Director positions at Gyros AB, Cellectricon AB, Light Sciences Oncology, Inc., NsGene A, MetaCure (USA), Inc., and Chempilots A. Education includes graduate studies at Copenhagen Business School, an MBA from Scandinavian International Management Institute, and undergraduate studies at Zealand Business College.
Postes actifs de Martin Olin
| Sociétés | Poste | Début |
|---|---|---|
| CESSATECH A/S | Président | 01/01/2022 |
AirHelp Ltd.
 AirHelp Ltd. Packaged SoftwareTechnology Services Develops mobile applications to claim compensation for delayed or cancelled flights | Directeur/Membre du Conseil | - |
RSP Systems A/S
 RSP Systems A/S Medical SpecialtiesHealth Technology Provides non-invasive solutions for sugar and insulin blood level measurements | Président | - |
Scanseason A/S | Président | - |
Anciens postes connus de Martin Olin
| Sociétés | Poste | Fin |
|---|---|---|
| ONCOINVENT ASA | Directeur Général | 21/11/2024 |
Nordic Eye Invest ApS
 Nordic Eye Invest ApS Investment ManagersFinance Fiftyfive Capital invests in companies located across the Nordic region. The firm targets companies operating in the fields of tech and lifestyle sectors. It provides financing for growth stage capital requirements. | Corporate Officer/Principal | 01/04/2021 |
Symphogen A/S
 Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Directeur Général | 04/06/2020 |
| ASCENDIS PHARMA A/S | Directeur/Membre du Conseil | 12/09/2018 |
SLS Invest ApS
 SLS Invest ApS MiscellaneousMiscellaneous Operates as a holding company | Directeur en chef des Investissements | 01/03/2012 |
Formation de Martin Olin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
25
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 25 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Gyros AB
 Gyros AB Medical SpecialtiesHealth Technology Engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays | Health Technology |
Cellectricon AB
 Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Provides cell-based screening services to accelerate drug discovery | Commercial Services |
Light Sciences Oncology, Inc.
 Light Sciences Oncology, Inc. Pharmaceuticals: MajorHealth Technology Provides light infusion therapy systems | Health Technology |
Copenhagen Business School
 Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NsGene A/S
 NsGene A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic products for the treatment of neurodegenerative disorders | Health Technology |
PreciSense A/S
 PreciSense A/S Electronic Equipment/InstrumentsElectronic Technology Develops and distributes non-invasive blood glucose monitoring systems | Electronic Technology |
Scandinavian Life Science Ventures AB
 Scandinavian Life Science Ventures AB Investment ManagersFinance SLS Invest is an active manager which provides financing for early, later, and growth-stage capital requirements, as well as providing management support. The firm targets companies operating in the health technology sector, and industries such as biotechnology and pharmaceuticals. It invests in young companies located in Northern Europe and the United States, and looks to take both minority and majority stake positions in its investments, as well as a seat on the board. | Finance |
Scandinavian International Management Institute
 Scandinavian International Management Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scandinavian Life Science Invest ApS
 Scandinavian Life Science Invest ApS Investment ManagersFinance Scandinavian Life Science Invest's investment strategy aims to maximize return on investments. They are active investors in growth firms in the life science sector primarily in the areas of pharmaceutical development, biotechnology and medical technology. They generally take stakes from 10% to 49% in each firm, seeking to influence but not through a controlling interest. They invest in small and mid-sized life science firms primarily in Scandinavia and Europe. They seek long-term capital growth by constructing diversified portfolios through sector, firm size, development stage and financial status. They provide a combination of capital, industrial and financial expertise to their portfolio firms. Scandinavian Life Science Invest prefers to invest in phases after seed capital but before IPO. They look for firms with a strong patent position, clear market potential, proven medical need for the product or technology, expert science and scientific teams and incentives for key employees. The firm's exit strategies include trade sales, IPO and M&A. | Finance |
PricewaterhouseCoopers (Denmark)
 PricewaterhouseCoopers (Denmark) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers (Denmark) is a company based in Hellerup, Denmark. | Commercial Services |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
Ascendis Pharma A/S
 Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
RSP Systems A/S
RSP Systems A/S Medical SpecialtiesHealth Technology Provides non-invasive solutions for sugar and insulin blood level measurements | Health Technology |
MetaCure (USA), Inc.
 MetaCure (USA), Inc. Pharmaceuticals: MajorHealth Technology Provides invasive treatment for diabetes | Health Technology |
BerGenBio ASA
 BerGenBio ASA Pharmaceuticals: MajorHealth Technology Develops drugs for aggressive, drug resistant cancers | Health Technology |
Zealand Business College
 Zealand Business College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chempilots A/S
 Chempilots A/S Miscellaneous ManufacturingProducer Manufacturing Develops polymer for the medical device and pharmaceutical industries | Producer Manufacturing |
AcouSort AB
 AcouSort AB Medical DistributorsDistribution Services Develops methods and devices for isolation of cells | Distribution Services |
AirHelp Ltd.
AirHelp Ltd. Packaged SoftwareTechnology Services Develops mobile applications to claim compensation for delayed or cancelled flights | Technology Services |
SLS Invest ApS
SLS Invest ApS MiscellaneousMiscellaneous Operates as a holding company | Miscellaneous |
Nordic Eye Invest ApS
Nordic Eye Invest ApS Investment ManagersFinance Fiftyfive Capital invests in companies located across the Nordic region. The firm targets companies operating in the fields of tech and lifestyle sectors. It provides financing for growth stage capital requirements. | Finance |
Scanseason A/S | |
Nordic Eye Management ApS
 Nordic Eye Management ApS Financial ConglomeratesFinance Provides financial intermediation services | Finance |
Cessatech A/S
 Cessatech A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for children for the treatment of pediatric acute pain | Health Technology |
